LYMPHOMA IN AN HIV-POSITIVE PATIENT

Authors

  • Carmen MANCIUC University of Medicine and Pharmacy”Grigore T. Popa”- Iasi
  • Carmen DOROBAT University of Medicine and Pharmacy”Grigore T. Popa”- Iasi
  • C. DANAILA University of Medicine and Pharmacy”Grigore T. Popa”- Iasi
  • Maria Alexandra LARGU University of Medicine and Pharmacy”Grigore T. Popa”- Iasi

Abstract

HIV/AIDS is considered to be revealing of oncological diseases, of which most frequent are lymphomas. The main causes for this type of disease are non-adherence and non-compliance to antiretroviral therapy (ART). We are hereby presenting a clinical case of lymphoma in an HIV-infected adult, with non-adherence for 30 months. In such a case the interdisciplinary collaboration with the hematologist was essential for the patient’s survival.

Author Biographies

  • Carmen MANCIUC, University of Medicine and Pharmacy”Grigore T. Popa”- Iasi

    Faculty of Medicine
    Department of Medical Specialties (II)

  • Carmen DOROBAT, University of Medicine and Pharmacy”Grigore T. Popa”- Iasi

    Faculty of Medicine
    Department of Medical Specialties (II)

  • C. DANAILA, University of Medicine and Pharmacy”Grigore T. Popa”- Iasi

    Faculty of Medicine
    Department of Medical Specialties (II)

  • Maria Alexandra LARGU, University of Medicine and Pharmacy”Grigore T. Popa”- Iasi

    Faculty of Medicine
    Department of Preventive Medicine and Interdisciplinarity

References

1. Jallow A, Ljunggren G, Wändell P, Carlsson AC. Prevalence, incidence, mortality and co-morbidities amongst human immunodeficiency virus (HIV) patients in Stockholm County, Sweden - The Greater Stockholm HIV Cohort Study. AIDS Care. 2014:1-8.
2. Cobucci RN, Lima PH, de Souza PC, Costa VV, Cornetta MD, Fernandes JV, Gonçalves AK. As-sessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: A systematic review. J Infect Public Health. 2015; 8(1): 1-10
3. Manciuc C, Dorobat C, Astărăstoae V, Largu MA. The HIV-positive patient in intensive care –psychological profile, Rev Med Chir, 2014; 118(3): 738-743.
4. Manciuc C, Largu MA, Vâţă, A, Nicolau C., Prisăcariu L, Stoica D, Dorobăţ C. Calitatea vietii la pacientii Centrului Regional HIV/SIDA din Iasi. Rev Med Chir. 2011; 115(4): 1214-1218.
5. Csarman E. Pathology of lymphoma in HIV. Curr Opin Oncol 2013; 25(5): 487–494.
6. Jacobson CA, Abramson JS. HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART. Advances in Hematology. 2012: 507257. doi: 10.1155/2012/507257. Epub 2012 Jan 5
7. Carbone A, Gloghini A, Serraino D, Spina M. HIV-associated Hodgkin lymphoma. Curr Opin HIV AIDS 2009; 4(1): 3-10.
8. Le Moal G, Prazuck T, Saberan-Roncato M, Julien J, Pasdeloup T, Descamps JM, Lestelle M, Arsac P, Champeaux-Orange E, Bouaraba L, Hocqueloux L. Immuno-virological and clinical impacts of treating cancer in patients living with HIV. J Antimicrob Chemother 2015; 70(1): 249-256.

Additional Files

Published

2015-03-31

Issue

Section

INTERNAL MEDICINE - PEDIATRICS